Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dipender Gill

Showing results (231-240 of 325) with videos related to

Pageof 33
Sort By:
The Lancet Regional Health. Southeast Asia|July 21, 2025
Identification of protein targets for dyslipidaemia and cardiovascular diseases among people with South Asian ancestry: a mendelian randomisation studySiwei Wu, Devendra Meena, Alexander Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Prioritizing protein targets for dyslipidaemia and cardiovascular diseases using Mendelian randomization in South AsiansSiwei Wu, Alexander Smith, Jingxian Huang, et al.
Journal of Advanced Research|April 8, 2026
Antidiabetic drug effects on gastrointestinal health: convergent evidence from a longitudinal cohort and Mendelian randomization studyXinxuan Li, Jie Chen, Lijuan Wang, et al.
BMC Medicine|August 10, 2022
Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroupsMarios K Georgakis, Rainer Malik, Tom G Richardson, et al.
Npj Women'S Health|March 3, 2026
Menopausal hormone therapy and risk of neuropsychiatric disease: a drug target Mendelian randomisation studyLouise S Schindler, Dipender Gill, Hannah Oppenheimer, et al.
Neurology|January 23, 2024
Mendelian Randomization Applied to Neurology: Promises and ChallengesEloi Gagnon, Iyas Daghlas, Loukas Zagkos, et al.
European Heart Journal Open|June 27, 2024
Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targetsEloi Gagnon, Arnaud Girard, Jérôme Bourgault, et al.
Nature Communications|August 15, 2019
GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traitsRaha Pazoki, Evangelos Evangelou, David Mosen-Ansorena, et al.
Neurology|July 3, 2020
Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypesMarios K Georgakis, Dipender Gill, Alastair J S Webb, et al.
Plos Medicine|December 29, 2022
Associations of genetically predicted fatty acid levels across the phenome: A mendelian randomisation studyLoukas Zagkos, Marie-Joe Dib, Rui Pinto, et al.
Pageof 33

Showing results (231-240 of 325) with videos related to

Sort By:
Pageof 33
The Lancet Regional Health. Southeast Asia|July 21, 2025
Identification of protein targets for dyslipidaemia and cardiovascular diseases among people with South Asian ancestry: a mendelian randomisation studySiwei Wu, Devendra Meena, Alexander Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Prioritizing protein targets for dyslipidaemia and cardiovascular diseases using Mendelian randomization in South AsiansSiwei Wu, Alexander Smith, Jingxian Huang, et al.
Journal of Advanced Research|April 8, 2026
Antidiabetic drug effects on gastrointestinal health: convergent evidence from a longitudinal cohort and Mendelian randomization studyXinxuan Li, Jie Chen, Lijuan Wang, et al.
BMC Medicine|August 10, 2022
Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroupsMarios K Georgakis, Rainer Malik, Tom G Richardson, et al.
Npj Women'S Health|March 3, 2026
Menopausal hormone therapy and risk of neuropsychiatric disease: a drug target Mendelian randomisation studyLouise S Schindler, Dipender Gill, Hannah Oppenheimer, et al.
Neurology|January 23, 2024
Mendelian Randomization Applied to Neurology: Promises and ChallengesEloi Gagnon, Iyas Daghlas, Loukas Zagkos, et al.
European Heart Journal Open|June 27, 2024
Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targetsEloi Gagnon, Arnaud Girard, Jérôme Bourgault, et al.
Nature Communications|August 15, 2019
GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traitsRaha Pazoki, Evangelos Evangelou, David Mosen-Ansorena, et al.
Neurology|July 3, 2020
Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypesMarios K Georgakis, Dipender Gill, Alastair J S Webb, et al.
Plos Medicine|December 29, 2022
Associations of genetically predicted fatty acid levels across the phenome: A mendelian randomisation studyLoukas Zagkos, Marie-Joe Dib, Rui Pinto, et al.
Pageof 33